Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic hepatitis]

R Figueroa Barrios1

  • 1Universidad Nacional Mayor de San Marcos.

Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Chronic hepatitis, a persistent liver inflammation from viruses or drugs, can lead to cirrhosis and liver cancer. Current treatments like interferon alfa show promise for hepatitis B and C, controlling disease progression in many patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Portosystemic encephalopathy].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·1991
Same author

[Study of gastric secretion in liver cirrhosis].

Anales. Universidad Nacional Mayor de San Marcos. Facultad de Medicina·1967
Same journal

[Adolescent with severe liver disease and positive autoantibodies: when Wilson's disease presents as autoimmune hepatitis].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·2026
Same journal

[Cholestatic jaundice revealing pylephlebitis associated with mesenteric venous thrombosis].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·2026
Same journal

[Severe acute pancreatitis secondary to the use of immune checkpoint inhibitors].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·2026
Same journal

[Exocrine pancreatic insufficiency and hyperoxaluria: a preventable renal complication from gastroenterology].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·2026
Same journal

[Lymphocytic esophagitis as a cause of dysphagia: a case report and brief literature review].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·2026
Same journal

Management of early rectal cancer with massive submucosal invasion using endoscopic intermuscular dissection: a case report.

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Chronic hepatitis is a persistent liver inflammation with diverse etiologies including viral infections, drug toxicity, and autoimmune processes.
  • The disease can progress to severe outcomes such as liver cirrhosis and hepatocellular carcinoma.
  • Traditional histological classifications are being replaced by etiological diagnoses.

Purpose:

  • To review the medical literature on chronic hepatitis, focusing on its classification, etiology, and management.
  • To highlight diagnostic challenges and therapeutic strategies for different types of chronic hepatitis.

Summary:

  • Chronic hepatitis encompasses viral (hepatitis B, hepatitis C), autoimmune, and drug-induced forms.
  • Hepatitis B and C are treated with antiviral therapies like interferon alfa, achieving disease control in 30-40% of patients.

Related Experiment Videos

  • Autoimmune hepatitis may respond to long-term corticosteroid therapy, though diagnostic associations with hepatitis C virus can complicate management.

    • Impact:

    • Improved understanding of chronic hepatitis etiology aids in targeted treatment strategies.
    • Antiviral therapies offer a means to control chronic hepatitis B and C, potentially preventing progression to cirrhosis and liver cancer.
    • Ongoing research into alternative and combination therapies aims to enhance treatment efficacy for chronic hepatitis.